Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/Net Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 2.201.171.592.061.17

What is the latest EV/Net Sales ratio of AUROBINDO PHARMA ?

The latest EV/Net Sales ratio of AUROBINDO PHARMA is 2.20 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20242.20
Mar20231.17
Mar20221.59
Mar20212.06
Mar20201.17

How is EV/Net Sales of AUROBINDO PHARMA Trending?

Years EV/Net Sales % Change
Mar2024 2.2
88.03
Mar2023 1.17
-26.42
Mar2022 1.59
-22.82
Mar2021 2.06
76.07
Mar2020 1.17 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/Net Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹61,448.6 Cr -1.4% -7.1% -27.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr 1.8% -3.6% -7.1% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -2.8% -12.1% 24% Stock Analytics
CIPLA ₹122,835.0 Cr 2.3% 2.4% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 2.9% 6.5% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 2% -2.4% -13.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-1.4%

-7.1%

-27.3%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses